Biochemical target and mechanism of action
Upon entering the body, the prodrug (mycophenolate mofetil) undergoes metabolic conversion and releases the active substance—mycophenolic acid. At the biochemical level, this compound acts as a highly selective and fully reversible inhibitor of a specific enzyme called inosine monophosphate dehydrogenase (IMPDH).
Under normal physiological conditions, the enzyme IMPDH plays a key role in purine metabolism. It catalyzes a vital reaction: the conversion of inosine monophosphate (IMP) into xanthosine monophosphate. The latter, in turn, is the direct biochemical precursor of guanosine monophosphate (GMP).
When mycophenolic acid blocks IMPDH, this cascade is interrupted. As a result, the cellular synthesis of guanosine nucleotides via the de novo pathway (i.e., "from scratch") sharply decreases. Since purine nucleotides are essential building blocks for creating new nucleic acid strands, their deficiency inevitably leads to the suppression of DNA synthesis. Without DNA replication, normal cell division becomes impossible.
Rationale for selective action
The pharmacological value of mycophenolic acid lies in its selectivity. The drug predominantly suppresses the proliferation of immune cells, namely T lymphocytes and B lymphocytes.
This selectivity is explained by the characteristics of cellular metabolism. The fact is that for T and B lymphocytes, purine synthesis via the de novo pathway is critically important and virtually the only way to obtain material for DNA synthesis. With the GMP deficiency caused by IMPDH blockade, lymphocytes lose their ability to proliferate, which provides a potent immunosuppressive effect.
At the same time, other cells in the human body possess metabolic flexibility. To obtain the necessary nucleotides, they are able to use alternative biochemical routes—the so-called salvage pathways. Thanks to these bypass pathways, most body tissues suffer significantly less from the effects of mycophenolic acid than the lymphocytic lineage.
Indications for clinical use
The drug has found widespread use in two major fields of medicine: transplantology and rheumatology.
- Solid organ transplantation. Mycophenolate mofetil is included in immunosuppressive regimens to prevent graft rejection after heart, kidney, and liver transplantation.
- Autoimmune diseases. The drug is used in maintenance therapy for systemic lupus erythematosus. In addition, it is used to treat idiopathic thrombocytopenic purpura.
Important pharmacological feature: in the treatment of systemic lupus erythematosus and idiopathic thrombocytopenic purpura, the drug is prescribed in low doses, unlike the massive therapy used in organ transplantation.
Side effects and contraindications
Despite high selectivity for lymphocytes, therapy with mycophenolic acid can cause a number of adverse reactions. Side effects most commonly affect systems with actively dividing cells:
- Gastrointestinal tract (GIT): patients frequently complain of dyspeptic symptoms, including nausea, vomiting, and diarrhea.
- Hematopoietic system: bone marrow suppression manifests as changes in the complete blood count, primarily the development of anemia and leukopenia.
An absolute contraindication to the prescription of mycophenolic acid is pregnancy. The drug has pronounced teratogenic potential and can cause irreparable harm to the developing fetus.
Briefly: answers to topical questions
What immunosuppressants are combined with mycophenolate mofetil during transplantation?
The provided sources indicate that mycophenolate mofetil is used in heart, kidney, and liver transplantation, but do not specify which immunosuppressants it is combined with specifically during transplantation. For systemic lupus erythematosus, the possibility of combination with calcineurin inhibitors—cyclosporine or tacrolimus—is described.
What birth defects does mycophenolic acid cause in the fetus?
The provided study guides lack information on the specific types of birth defects caused by mycophenolic acid in the fetus, though they indicate a high risk of teratogenic effects and the contraindication of the drug during pregnancy.
To easily remember the drug's target, use a simple association: MYCophenolate Makes Inosine monophosphate dehydrogenase (IMPDH) Guano-fail (halts Guanosine).
Class and exam questions
Why does mycophenolic acid suppress lymphocytes specifically rather than all cells in the body?
T and B lymphocytes depend critically on de novo purine synthesis, which is blocked by the drug. Other cells are able to use alternative salvage pathways for nucleotide synthesis and thus suffer significantly less.
Synthesis of which specific nucleotide is disrupted during IMPDH blockade?
The production of guanosine monophosphate (GMP) ceases. This occurs because the drug blocks the conversion of inosine monophosphate to xanthosine monophosphate—the direct precursor of GMP.
At what dosages is the drug used in autoimmune diseases?
In maintenance therapy for systemic lupus erythematosus and the treatment of idiopathic thrombocytopenic purpura, mycophenolate mofetil is prescribed in low doses.
What else to study on this topic
- Biochemical pathways of purine synthesis: de novo and salvage pathways
- The role of guanosine nucleotides in DNA synthesis and cell division
- Immunosuppressive regimens in kidney, liver, and heart transplantation
- Mechanisms of leukopenia and anemia development during cytostatic therapy
- Features of the treatment of idiopathic thrombocytopenic purpura
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Mycophenolic acid" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Regulating Immune Processes"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.